Residual lymph node disease after neoadjuvant chemotherapy predicts an increased risk of lymphedema in node-positive breast cancer patients.
Identifieur interne : 003206 ( Main/Exploration ); précédent : 003205; suivant : 003207Residual lymph node disease after neoadjuvant chemotherapy predicts an increased risk of lymphedema in node-positive breast cancer patients.
Auteurs : Michelle C. Specht [États-Unis] ; Cynthia L. Miller ; Melissa N. Skolny ; Lauren S. Jammallo ; Jean O'Toole ; Nora Horick ; Steven J. Isakoff ; Barbara L. Smith ; Alphonse G. TaghianSource :
- Annals of surgical oncology [ 1534-4681 ] ; 2013.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Aisselle, Association thérapeutique, Biopsie de noeud lymphatique sentinelle, Facteurs de risque, Femelle, Humains, Indice de masse corporelle, Lymphadénectomie (effets indésirables), Lymphoedème (diagnostic), Lymphoedème (étiologie), Maladie résiduelle (diagnostic), Maladie résiduelle (étiologie), Pronostic, Protocoles de polychimiothérapie antinéoplasique (effets indésirables), Récidive tumorale locale (), Stade de la tumeur, Sujet âgé, Sujet âgé de 80 ans ou plus, Traitement médicamenteux adjuvant (effets indésirables), Traitement néoadjuvant (effets indésirables), Tumeurs du sein (), Études de suivi, Études prospectives.
- MESH :
- diagnostic : Lymphoedème, Maladie résiduelle.
- effets indésirables : Lymphadénectomie, Protocoles de polychimiothérapie antinéoplasique, Traitement médicamenteux adjuvant, Traitement néoadjuvant.
- étiologie : Lymphoedème, Maladie résiduelle.
- Adulte, Adulte d'âge moyen, Aisselle, Association thérapeutique, Biopsie de noeud lymphatique sentinelle, Facteurs de risque, Femelle, Humains, Indice de masse corporelle, Pronostic, Récidive tumorale locale, Stade de la tumeur, Sujet âgé, Sujet âgé de 80 ans ou plus, Tumeurs du sein, Études de suivi, Études prospectives.
English descriptors
- KwdEn :
- Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols (adverse effects), Axilla, Body Mass Index, Breast Neoplasms (complications), Breast Neoplasms (therapy), Chemotherapy, Adjuvant (adverse effects), Combined Modality Therapy, Female, Follow-Up Studies, Humans, Lymph Node Excision (adverse effects), Lymphedema (diagnosis), Lymphedema (etiology), Middle Aged, Neoadjuvant Therapy (adverse effects), Neoplasm Recurrence, Local (complications), Neoplasm Recurrence, Local (therapy), Neoplasm Staging, Neoplasm, Residual (diagnosis), Neoplasm, Residual (etiology), Prognosis, Prospective Studies, Risk Factors, Sentinel Lymph Node Biopsy.
- MESH :
- adverse effects : Antineoplastic Combined Chemotherapy Protocols, Chemotherapy, Adjuvant, Lymph Node Excision, Neoadjuvant Therapy.
- complications : Breast Neoplasms, Neoplasm Recurrence, Local.
- diagnosis : Lymphedema, Neoplasm, Residual.
- etiology : Lymphedema, Neoplasm, Residual.
- therapy : Breast Neoplasms, Neoplasm Recurrence, Local.
- Adult, Aged, Aged, 80 and over, Axilla, Body Mass Index, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Middle Aged, Neoplasm Staging, Prognosis, Prospective Studies, Risk Factors, Sentinel Lymph Node Biopsy.
Abstract
Axillary lymph node dissection (ALND) is recommended for patients with clinically node-positive breast cancer and carries a risk of lymphedema>30%. Patients with node-positive breast cancer may consider neoadjuvant chemotherapy, which can reduce node positivity. We sought to determine if neoadjuvant chemotherapy reduced the risk of lymphedema in patients undergoing ALND for node-positive breast cancer.
DOI: 10.1245/s10434-012-2828-y
PubMed: 23689935
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001B40
- to stream PubMed, to step Curation: 001B40
- to stream PubMed, to step Checkpoint: 001B40
- to stream Ncbi, to step Merge: 005927
- to stream Ncbi, to step Curation: 005927
- to stream Ncbi, to step Checkpoint: 005927
- to stream Main, to step Merge: 003211
- to stream Main, to step Curation: 003206
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Residual lymph node disease after neoadjuvant chemotherapy predicts an increased risk of lymphedema in node-positive breast cancer patients.</title><author><name sortKey="Specht, Michelle C" sort="Specht, Michelle C" uniqKey="Specht M" first="Michelle C" last="Specht">Michelle C. Specht</name><affiliation wicri:level="2"><nlm:affiliation>Division of Surgical Oncology, Massachusetts General Hospital, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Surgical Oncology, Massachusetts General Hospital, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Miller, Cynthia L" sort="Miller, Cynthia L" uniqKey="Miller C" first="Cynthia L" last="Miller">Cynthia L. Miller</name></author><author><name sortKey="Skolny, Melissa N" sort="Skolny, Melissa N" uniqKey="Skolny M" first="Melissa N" last="Skolny">Melissa N. Skolny</name></author><author><name sortKey="Jammallo, Lauren S" sort="Jammallo, Lauren S" uniqKey="Jammallo L" first="Lauren S" last="Jammallo">Lauren S. Jammallo</name></author><author><name sortKey="O Toole, Jean" sort="O Toole, Jean" uniqKey="O Toole J" first="Jean" last="O'Toole">Jean O'Toole</name></author><author><name sortKey="Horick, Nora" sort="Horick, Nora" uniqKey="Horick N" first="Nora" last="Horick">Nora Horick</name></author><author><name sortKey="Isakoff, Steven J" sort="Isakoff, Steven J" uniqKey="Isakoff S" first="Steven J" last="Isakoff">Steven J. Isakoff</name></author><author><name sortKey="Smith, Barbara L" sort="Smith, Barbara L" uniqKey="Smith B" first="Barbara L" last="Smith">Barbara L. Smith</name></author><author><name sortKey="Taghian, Alphonse G" sort="Taghian, Alphonse G" uniqKey="Taghian A" first="Alphonse G" last="Taghian">Alphonse G. Taghian</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:23689935</idno><idno type="pmid">23689935</idno><idno type="doi">10.1245/s10434-012-2828-y</idno><idno type="wicri:Area/PubMed/Corpus">001B40</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001B40</idno><idno type="wicri:Area/PubMed/Curation">001B40</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001B40</idno><idno type="wicri:Area/PubMed/Checkpoint">001B40</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001B40</idno><idno type="wicri:Area/Ncbi/Merge">005927</idno><idno type="wicri:Area/Ncbi/Curation">005927</idno><idno type="wicri:Area/Ncbi/Checkpoint">005927</idno><idno type="wicri:Area/Main/Merge">003211</idno><idno type="wicri:Area/Main/Curation">003206</idno><idno type="wicri:Area/Main/Exploration">003206</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Residual lymph node disease after neoadjuvant chemotherapy predicts an increased risk of lymphedema in node-positive breast cancer patients.</title><author><name sortKey="Specht, Michelle C" sort="Specht, Michelle C" uniqKey="Specht M" first="Michelle C" last="Specht">Michelle C. Specht</name><affiliation wicri:level="2"><nlm:affiliation>Division of Surgical Oncology, Massachusetts General Hospital, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Surgical Oncology, Massachusetts General Hospital, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Miller, Cynthia L" sort="Miller, Cynthia L" uniqKey="Miller C" first="Cynthia L" last="Miller">Cynthia L. Miller</name></author><author><name sortKey="Skolny, Melissa N" sort="Skolny, Melissa N" uniqKey="Skolny M" first="Melissa N" last="Skolny">Melissa N. Skolny</name></author><author><name sortKey="Jammallo, Lauren S" sort="Jammallo, Lauren S" uniqKey="Jammallo L" first="Lauren S" last="Jammallo">Lauren S. Jammallo</name></author><author><name sortKey="O Toole, Jean" sort="O Toole, Jean" uniqKey="O Toole J" first="Jean" last="O'Toole">Jean O'Toole</name></author><author><name sortKey="Horick, Nora" sort="Horick, Nora" uniqKey="Horick N" first="Nora" last="Horick">Nora Horick</name></author><author><name sortKey="Isakoff, Steven J" sort="Isakoff, Steven J" uniqKey="Isakoff S" first="Steven J" last="Isakoff">Steven J. Isakoff</name></author><author><name sortKey="Smith, Barbara L" sort="Smith, Barbara L" uniqKey="Smith B" first="Barbara L" last="Smith">Barbara L. Smith</name></author><author><name sortKey="Taghian, Alphonse G" sort="Taghian, Alphonse G" uniqKey="Taghian A" first="Alphonse G" last="Taghian">Alphonse G. Taghian</name></author></analytic><series><title level="j">Annals of surgical oncology</title><idno type="eISSN">1534-4681</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Antineoplastic Combined Chemotherapy Protocols (adverse effects)</term><term>Axilla</term><term>Body Mass Index</term><term>Breast Neoplasms (complications)</term><term>Breast Neoplasms (therapy)</term><term>Chemotherapy, Adjuvant (adverse effects)</term><term>Combined Modality Therapy</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Lymph Node Excision (adverse effects)</term><term>Lymphedema (diagnosis)</term><term>Lymphedema (etiology)</term><term>Middle Aged</term><term>Neoadjuvant Therapy (adverse effects)</term><term>Neoplasm Recurrence, Local (complications)</term><term>Neoplasm Recurrence, Local (therapy)</term><term>Neoplasm Staging</term><term>Neoplasm, Residual (diagnosis)</term><term>Neoplasm, Residual (etiology)</term><term>Prognosis</term><term>Prospective Studies</term><term>Risk Factors</term><term>Sentinel Lymph Node Biopsy</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Aisselle</term><term>Association thérapeutique</term><term>Biopsie de noeud lymphatique sentinelle</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Indice de masse corporelle</term><term>Lymphadénectomie (effets indésirables)</term><term>Lymphoedème (diagnostic)</term><term>Lymphoedème (étiologie)</term><term>Maladie résiduelle (diagnostic)</term><term>Maladie résiduelle (étiologie)</term><term>Pronostic</term><term>Protocoles de polychimiothérapie antinéoplasique (effets indésirables)</term><term>Récidive tumorale locale ()</term><term>Stade de la tumeur</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Traitement médicamenteux adjuvant (effets indésirables)</term><term>Traitement néoadjuvant (effets indésirables)</term><term>Tumeurs du sein ()</term><term>Études de suivi</term><term>Études prospectives</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Antineoplastic Combined Chemotherapy Protocols</term><term>Chemotherapy, Adjuvant</term><term>Lymph Node Excision</term><term>Neoadjuvant Therapy</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Breast Neoplasms</term><term>Neoplasm Recurrence, Local</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Lymphedema</term><term>Neoplasm, Residual</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Lymphoedème</term><term>Maladie résiduelle</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Lymphadénectomie</term><term>Protocoles de polychimiothérapie antinéoplasique</term><term>Traitement médicamenteux adjuvant</term><term>Traitement néoadjuvant</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term><term>Neoplasm, Residual</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Breast Neoplasms</term><term>Neoplasm Recurrence, Local</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term><term>Maladie résiduelle</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Axilla</term><term>Body Mass Index</term><term>Combined Modality Therapy</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Middle Aged</term><term>Neoplasm Staging</term><term>Prognosis</term><term>Prospective Studies</term><term>Risk Factors</term><term>Sentinel Lymph Node Biopsy</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Aisselle</term><term>Association thérapeutique</term><term>Biopsie de noeud lymphatique sentinelle</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Indice de masse corporelle</term><term>Pronostic</term><term>Récidive tumorale locale</term><term>Stade de la tumeur</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Tumeurs du sein</term><term>Études de suivi</term><term>Études prospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Axillary lymph node dissection (ALND) is recommended for patients with clinically node-positive breast cancer and carries a risk of lymphedema>30%. Patients with node-positive breast cancer may consider neoadjuvant chemotherapy, which can reduce node positivity. We sought to determine if neoadjuvant chemotherapy reduced the risk of lymphedema in patients undergoing ALND for node-positive breast cancer.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Massachusetts</li></region></list><tree><noCountry><name sortKey="Horick, Nora" sort="Horick, Nora" uniqKey="Horick N" first="Nora" last="Horick">Nora Horick</name><name sortKey="Isakoff, Steven J" sort="Isakoff, Steven J" uniqKey="Isakoff S" first="Steven J" last="Isakoff">Steven J. Isakoff</name><name sortKey="Jammallo, Lauren S" sort="Jammallo, Lauren S" uniqKey="Jammallo L" first="Lauren S" last="Jammallo">Lauren S. Jammallo</name><name sortKey="Miller, Cynthia L" sort="Miller, Cynthia L" uniqKey="Miller C" first="Cynthia L" last="Miller">Cynthia L. Miller</name><name sortKey="O Toole, Jean" sort="O Toole, Jean" uniqKey="O Toole J" first="Jean" last="O'Toole">Jean O'Toole</name><name sortKey="Skolny, Melissa N" sort="Skolny, Melissa N" uniqKey="Skolny M" first="Melissa N" last="Skolny">Melissa N. Skolny</name><name sortKey="Smith, Barbara L" sort="Smith, Barbara L" uniqKey="Smith B" first="Barbara L" last="Smith">Barbara L. Smith</name><name sortKey="Taghian, Alphonse G" sort="Taghian, Alphonse G" uniqKey="Taghian A" first="Alphonse G" last="Taghian">Alphonse G. Taghian</name></noCountry><country name="États-Unis"><region name="Massachusetts"><name sortKey="Specht, Michelle C" sort="Specht, Michelle C" uniqKey="Specht M" first="Michelle C" last="Specht">Michelle C. Specht</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003206 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003206 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:23689935
|texte= Residual lymph node disease after neoadjuvant chemotherapy predicts an increased risk of lymphedema in node-positive breast cancer patients.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:23689935" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |